NFKB1 and colorectal cancer: While VEGF signaling was not directly evaluated in our study, recent research in a model of colorectal cancer angiogenesis suggests that NIKi may limit angiogenesis by targeting the noncanonical NF-κB pathway, which can act as a compensatory mechanism when VEGF signaling is compromised [54].